Research Reports

Key takeaways

Mr Phillip Hains resigned as Chief Financial Officer and Joint Company Secretary.

Acclime Australia nominated Mr Aaron Laurita as new Chief Financial Officer; he has biotechnology sector experience across Australia, US, and Canada.

Ms Amritha Sushil appointed as Joint Company Secretary; she is a Chartered Secretary with corporate governance expertise.

Mr Nathan Jong continues as Joint Company Secretary.

Changes effective immediately; Acclime Australia continues providing financial and secretarial services.

Ms Sushil and Mr Jong responsible for ASX communications per Listing Rule 12.6.

Full analysis

The leadership changes in finance and company secretarial functions involve key resignations and appointments through the ongoing agreement with Acclime Australia. Mr Hains' departure from CFO and Joint Company Secretary roles prompts a seamless transition with Mr Laurita's nomination, leveraging his decade of finance experience in biotechnology across multiple countries and qualifications as a Chartered Accountant. The addition of Ms Sushil strengthens governance expertise, while Mr Jong's continuity ensures stability. These immediate changes maintain service continuity without disruption to statutory reporting or ASX communications, signaling effective contingency planning for investor confidence in administrative functions.

RADX · Radiopharm Theranostics Limited

Summary

Key takeaways

Full analysis